|
HRKorea |
ÀÓ»ó½ÃÇè Ã¥ÀÓÀÚ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
06.25 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
ÀÓ»óÆÀÆÀÀå/±¹³»Áß°ßÁ¦¾àȸ»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
04.19 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[À¯¸íÁ¦¾à»ç] ÀÓ»ó ÆÀÀå (ÀçÅð¡´É)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
04.12 |
|
|
(ÁÖ)ÄھƼġ |
Clinical Quality&Training Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
12.28 |
|
|
ÆÊÄ¿³ØÆà |
[Global CRO] ÄÚ¾îÆÀ CTM
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
05.31 |
04.16 |
|
|
ÆÊÄ¿³ØÆà |
[´ë±â¾÷ ÀÚȸ»ç] ÀÓ»óPM
¼¿ï °¼±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
05.31 |
04.09 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
ÀÓ»óÆÀÆÀÀå/±¹³»Áß°ßÁ¦¾àȸ»ç
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
01.25 |
|
|
ÆÊÄ¿³ØÆà |
[Áß°ß Á¦¾à»ç] ÀÓ»óPM
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
05.31 |
04.16 |
|
|
scout |
CRM °æ·Â -[À¯¸í ±Û·Î¹ú CRO]
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
02.04 |
|
|
(ÁÖ)¶ó¿Â¼Ä¡ |
±×·ìÁ¦¾à»ç - Clinical Project Management (´ë¸®°úÀå±Þ)
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
07.14 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Therapy Advancement Manager(CRM)/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
11.21 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[·ÎÄà CRO] ¸Å´ÏÀú (CRA °æ·Â 6³âÀÌ»ó Áö¿ø °¡´É)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
04.04 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[±¹³»Á¦¾à»ç] ÇØ¿ÜÀÓ»óPM / ¸¶°î/ Ãâ±ÙÀ¯¿¬Á¦
¼¿ï °¼±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
07.06 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹ÀûÁ¦¾àȸ»ç CPL (Clinical Project Leader)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
09.27 |
|
|
ÆÄÀε崺·ÎµåÄÁ¼³Æà |
¿Ü±¹°è Á¦¾à»ç Clinical trial manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
05.03 |
|